Abeona Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABEO and other ETFs, options, and stocks.

About ABEO

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). 

CEO
Vishwas Seshadri
CEOVishwas Seshadri
Employees
90
Employees90
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1974
Founded1974
Employees
90
Employees90

ABEO Key Statistics

Market cap
66.13M
Market cap66.13M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
255.65K
Average volume255.65K
High today
High today
Low today
Low today
Open price
$3.85
Open price$3.85
Volume
0.00
Volume0.00
52 Week high
$17.50
52 Week high$17.50
52 Week low
$2.70
52 Week low$2.70

ABEO Earnings

-$4.50
-$3.00
-$1.50
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 30, Pre-Market
ActualExpected Mar 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.